sinaror7 Corticosteroids The Dept of Anaesthesia & Intensive Care, CUHK thanks MAQUET for an uestricted edvcation grant BASIC instructor/ provider course, Hong Kong, July 2nd-ath ‘Other upcoming courses, tome | Feeback | contents | Corticosteroids =» u ACE tnibitors Adenosine Anaphylacts Antiarrhythmics Antibecterias Anticoagulants Anti-rinoytics dntifungats Antilatelet drugs Antiviral Beta agonists Ca antagonists Corticosteroids Erythropoietin Fosphenytoin Hydraazine Immunosuppressants Inatropes @.vasopressors Insulin 1 inmunoglebutin Labetalel aretel etocopramide Nescetyleysteine Nesiritise Neurotic malignant syn Nitric oxide Nitroprussie Proton pump inhibitors sedatives Serotonin syndrome Sucratate suxamethontum Theophytine Vasopressin Corticosteroids Mechanism of action D enter cells where they combine with steroid receptors in cytoplasm 1 combination enters nucleus where it controls synthesis of protein, including enzymes that regulate vital cell activities over a wide range of metabolic functions including all aspects of inflammation D formation of a protein that inhibits the enzyme phospholipase A which is needed to allow the supply of arachidonic acid. Latter is essential for the formation of inflammatory mediators D also act on cell membranes to alter ion permeability 1D also modify the production of neurohormones Actions Important to distinguish between physiological effects (replacement therapy) and pharmacological effects (occur at higher doses) Mineralocorticoid 1 Na retention by renal tubule increased K excretion in urine ipsshwunw dic curk eduhkiwebeoricosterids him “4sinaror7 Corticosteroids Glucocorticoid 1D CHO metabolism: increased gluconeogenesis, @ peripheral glucose uptake may be decreased with resultant hyperglycaemia @ glycosuria 1 protein metabolism: anabolism is decreased but catabolism continues unabated or is increased resulting in negative N balance and muscle wasting. Osteoporosis occurs, growth slows in children, skin atrophies (together with increased capillary fragility leads to bruising and striae), healing and fibrosis delayed 1 fat deposition: increased on shoulders, face and abdomen 1D inflammatory response depressed D allergic response depressed 1 antibody production reduced by large doses Di lymphoid tissue reduced (including leukaemic lymphocytes) Di decreased eosinophils Di renal urate excretion increased 1 euphoria or psychotic states may occur. ? due to CNS electrolyte changes D anti-vitamin D action 1 reduction of hypercalcaemia (chiefly where this is due to increased absorption from gut: vit D intoxication, sarcoidosis) 1D increased urinary Ca excretion. Renal stones may form DI growth reduction where new cells are being added (eg in children) but not where they are replacing cells as in adult tissues 1 suppression of HPA axis. NB steroid suppressed adrenal continues to secrete aldosterone Normal daily secretion of hydrocortisone is 10-30 mg. Exogenous daily dose that completely suppresses cortex is 40-80 mg (or prednisolone 10-20 mg). Individual steroids Relative potencies | Glucocorticoid | Mineralocorticoid Hydrocortisone 1 1 Cortisol 1.25 1 Prednisolone 4 0.8 Methylprednisotone | 5 minimal Dexamethasone 30 minimal Fludrocortisone 15 150 I prednisolone is standard choice for anti-inflammatory therapy. Can be given orally or IM 1 methylprednisolone used for IV pulsed therapy 1 dexamethasone longer acting. 1 fludrocortisone used to replace aldosterone where the adrenal cortex has been destroyed Fipsshwenw ic curk eduhiwebSeoricosterids him 2sga0s7 Certostercids 1 beclomethasone and budesonide used by inhalation for asthma. About 90% of inhalation dose is swallowed and inactivated by first-pass hepatic metabolism (steroids listed above are protected from this by protein binding). The rest, which is absorbed from the mouth and lungs gives very low systemic plasma concentrations. Although risk of HPA axis suppression is very low it can happen. Pharmacokinetics Administration: PO/IM/IV/intra-articular/topical/inhaled. Absorption after oral administration is rapid. Maximum biological effect seen after 2-8 h Distribution: high plasma protein binding (95% in case of hydrocortisone) to transcortin and when this is saturated to albumin (80% in the case of hydrocortisone). Concentration of transcortin is increased by oestrogens (eg pregnancy, oral contraceptives). In patients with very low serum albumin doses should be reduced due to reduced binding capacity Elimination: hepatic and renal.ty 2 of most steroids 1-3 h. Prolonged in renal and hepatic disease and shortened by hepatic enzyme induction to an extent that may be clinically important. Adverse effects In general serious unwanted effects are unlikely if daily dose is < 50 mg hydrocortisone or 10mg of prednisolone or equivalent D iatrogenic Cushings D avascular necrosis of bone 1 depression and psychosis 1D peptic ulceration 1 others include cataract (chronic use), glaucoma (prolonged use of eye drops), raised ICP and convulsions, blood hypercoagulability, menstrual disorders, fever 1 immunosuppression 1 HPA axis suppression: dependent on steroid used, dose, duration of administration and time of administration. Single morning dose of <20mg prednisolone does not usually cause suppression while 5mg in evening suppresses early morning activation of HPA axis Use in pregnancy Di teratogenic in animals 1 ? relationship between high dose steroids and cleft palate and other fetal abnormalities D adrenal insufficiency due to HPA axis suppression in newborn only occurs with high maternal doses 1 keep doses as low as possible in pregnancy 1D avoid fluorinated steroids (eg dexamethasone) as they are more teratogenic in animals Treatment of intercurrent illness 1 maximum stress-induced output of cortisol is 200-300 mg/day Fipsshwenw ic curk eduhiwebSeoricosterids him a4sinaror7 Corticosteroids 1D production following surgery tends to be much less. Based on normal cortisol production rates the recommended daily doses of hydrocortisone equivalent for different categories of surgery are: Daily dose Duration Minor (eg hernia repair) 25 mg 1 day Intermediate (eg cholecystectomy, 50-75 mg 2 days colectomy, joint replacement) Major (eg oesophagectomy, cardiac 100-150 mg 2-3 days surgery requiring CPB) If the patients maintenance dose exceeds recommended dose to cover surgical stress there is no evidence that any dose alteration is necessary and patient should continue to receive maintenance dose over the perioperative period. In the case of perioperative complications continued glucocorticoid administration consistent with the postoperative stress response is appropriate Further reading Laurence DR, Bennett PN. Clinical Pharmacology, 7" ed, 1992 Chin R, Eagerton DC, Salem M. Corticosteroids. In Chernow B (ed). The pharmacological approach to the critically ill patient, 3" ed, 1994 @ Charles Gomersall December 1999 ‘@Chares Gomersal, April, 2014 ures otherwise stated. Th autor, editor and The Chinese Usivesty of Hong Kong take no responsibility for any adverse event Fesulting fram the eof tis webpage ‘Sowa policy” Conributors Fipsshwenw ic curk eduhiwebSeoricosterids him 4s